Status:
COMPLETED
An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care
Lead Sponsor:
Mayo Clinic
Conditions:
Advanced Malignant Female Reproductive System Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial tests an artificial intelligence (AI) algorithm for its ability to identify patients who may benefit from a palliative care consult for gynecologic cancer that has spread from wher...
Detailed Description
PRIMARY OBJECTIVE: I. To pilot an oncology risk prediction model to identify patients who may benefit from outpatient palliative care consultation to improve symptom management and goal-concordant ca...
Eligibility Criteria
Inclusion
- Adult patient in Enhanced, Electronic health record (EHR)-facilitated Cancer Symptom Control (E2C2) with a diagnosis of advanced gynecologic malignancy (International Classification of Diseases \[ICD\] codes C51 through C58)
- Weekly the reviewers will select patients by looking at patients in sorted order starting with the highest score and proceeding down the list and evaluating each patient for exclusion criteria
Exclusion
- Patients that have been seen by palliative care will be excluded for 75 days
- Patients under the age of 18 years
- Patients currently enrolled with hospice
Key Trial Info
Start Date :
December 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 26 2024
Estimated Enrollment :
221 Patients enrolled
Trial Details
Trial ID
NCT06182332
Start Date
December 11 2023
End Date
July 26 2024
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905